Endovascular treatment has been increasingly performed for unruptured intracerebral aneurysms. However, thromboembolic complications, which develop mostly within 48 hours after the procedure, are the most common and major complications of endovascular treatment. We present a rare case of delayed symptomatic thromboembolism in an ischemic stroke patient who had undergone coil embolization for unruptured middle cerebral artery (MCA) aneurysm.
INTRODUCTION
Endovascular coil embolization has been an effective treatment modality for the treatment of unruptured intracranial aneurysms. However, major procedural complications have occasionally occurred, including thromboembolism and aneurysm perforation. In addition, vasospasm, hemodynamic ischemia, migration or reconfiguration of coils and subsequent enlargement of the neck or sac were recognized as pivotal limitations of endovascular coil embolization. 8) Thromboembolic events are the most common complication of endovascular treatment, and they may be caused by thrombus formation from the catheter or guidewire, or breakdown of the thrombus from the aneurysm, in which coils have been packed, into the parent artery. 5) Most thromboembolic complications occur within 48 hours of endovascular treatment; therefore, antiplatelet or anticoagulant is used during the procedure.
1)
However, delayed thromboembolic event beyond 2 days after coil embolization may occur despite its rarity.
Here, we present a case of delayed symptomatic thromboembolism which occurred 19 days after the coil embolization of an unruptured aneurysm despite antiplatelet therapy.
CASE REPORT
A 56-year-old woman presented to the emergency room with mild left leg numbness of sudden onset.
The symptoms had a rapidly improving course over a period of one week. She had hypertension and diabetes mellitus as stroke risk factors. In addition, she had experienced hypertensive intracerebral hemor- . 19 days later, sensory aphasia and right arm weakness developed. The DWI reveals some scattered infarction in the territory of the distal part of the embolized vessels (E) and the angiogram shows a filling defect as a thrombus in the aneurysm just distal to them (F). Control angiogram after intra-arterial thrombolysis showed complete resolution of thrombus and contrast filling of the coiled aneurysm sac (G).
one. The result of her chest x-ray and electrocardiogram showed a normal configuration. A brain magnetic resonance imaging (MRI) scan taken 3 hours 46 minutes after the onset and diffusion-weighted imaging (DWI) showed an acute lacunar infarct in the right thalamus, which may be correlated with small vessel disease, without perfusion defects (Fig 1-A) . (Fig 1-B) . Coiling rather than clipping was considered because of acute thalamic infarction, patient's age, and preponderance of the patient. Because of no recurrent ischemic attack or neurologic deficits, treatment timing was considered beyond acute period (minimum 2 weeks after initial attack). Therefore, coil embolization using a multiple catheter technique was performed at hospital day 15. The partial embolization was performed without difficulty because dense packing of the aneurysm was intentionally avoided to prevent protrusion of the Guglielmi Detachable Coils into the parent vessels or occlusion of the parent artery. Consequently, postprocedual imaging could detect some contrast filling in the aneurysmal sac (Fig 1-C, D) . The patient was discharged without recurrent or residual neurological deficits and maintained dual antiplatelet agents. (Fig 1-E) , and then TFCA was performed without additional images and showed a filling defect as a thrombus in the proximal MCA just distal to the aneurysmal neck (Fig 1-F) . Therefore, we performed intra-arterial thrombolytic therapy using 100,000 units of urokinase (for thrombolysis) and 500 mcg abciximab (for inhibiting platelet aggregation) without intravenous tissue plasminogen activator.
Immediate post-thrombolysis angiography showed a resolved thrombus and good blood flow to the left MCA branches (Fig 1-G) . Language disturbance and motor weakness were not observed. Seven days after the thrombolysis, TFCA revealed still complete recanalization of the thrombosed parent artery. Dual antiplatelet agents were maintained, and she had no recurrent neurological symptoms 12 month after the intra-arterial thrombolytic therapy.
DISCUSSION
We reported a case of delayed thromboembolic complications after endovascular coil embolization of an unruptured MCA aneurysm. In addition, our case had delayed thromboembolic events despite antiplatelet medication.
The peri-procedural ischemic stroke following endovascular coil embolization of aneurysms has been reported in 1 to 28% of cases. Studies with immediate DWI after embolization showed a higher frequency of silent embolism than symptomatic infarct. by the multiple microcatheter technique. 3) Nevertheless, they were focused on the periprocedural period rather than the period afterward. Besides, it has not been determined whether dual antiplatelet therapy is more effective than a single antiplatelet agent on thromboembolic events.
Our patient had a high risk of thromboembolism in that she had an unfavorable aneurysm which led to using multiple microcatheters; moreover partial embolization was performed. Accordingly, in patients with high risk of antiplatelet resistance or ischemic stroke, we postulate that single antiplatelet therapy might be insufficient to prevent a thromboembolic event.
CONCLUSION
Although the mechanism of thrombus formation in this case is uncertain, we suggest that prolonged dual antiplatelet therapy beyond the peri-procedural period may be considered in patients with high risk of ischemic events.
